Surpim IM/IV Injection

About Surpim IM/IV 30 mg/ml Injection

Surpim IM/IV comes as a injection with 30 mg/ml of Ketorolac Tromethamine, from Asiatic Laboratories Ltd. It should not be used as a preventive painkiller before surgery.

There are 106 brands of Ketorolac Tromethamine listed in Bangladesh. The lowest listed price is Painlac 10 mg Tablet at ৳ 1 per unit.

What is Surpim IM/IV 30 mg/ml Injection?

Surpim IM/IV is a injection from Asiatic Laboratories Ltd., with the generic name Ketorolac Tromethamine. At its pain-relieving dose it has only a small anti-inflammatory effect. It is given for the short-term management of moderate to severe acute pain after surgery. The doctor decides who can receive it, the dose and how long it is used.

Uses of Surpim IM/IV

It should not be used as a preventive painkiller before surgery. It belongs to the non-steroidal anti-inflammatory drug group, and it is given when pain is severe enough to need strong pain relief. It belongs to the NSAID class of medicines, often described as strong pain relievers. Ask your doctor or pharmacist if you are unsure why they have been prescribed.

How to use Surpim IM/IV

Surpim IM/IV is given by a doctor or nurse as an injection, either into a vein or into a muscle. Do not inject it yourself unless a doctor has shown you how. Surpim IM/IV is given as an injection by a healthcare professional. Swallow the injection whole with water. The doctor decides the dose, how often it is given and for how long. Tell your doctor or pharmacist about any other medicines you take before treatment.

Side effects of Surpim IM/IV

Surpim IM/IV can cause side effects. Patients should tell the doctor or nurse promptly if they notice any unusual symptom after receiving the injection. Commonly reported ones include nausea, vomiting, gastrointestinal bleeding, dark stools, peptic ulcer, pancreatitis, anxiety, drowsiness, headache, excessive thirst, fatigue, slow heartbeat, high blood pressure, palpitations, chest pain, infertility in women and pulmonary edema. Tell your doctor promptly if you notice stomach pain, black stools, chest pain or any unusual symptom.

Safety and precautions

Extra caution is needed in older patients. Surpim IM/IV 30 mg/ml injection must not be used by anyone allergic to it or to other NSAIDs, in children, or as a preventive painkiller before surgery. Surpim IM/IV injection should not be used by people allergic to ketorolac or other NSAIDs. Ask your doctor first if any of these apply to you.

Frequently asked questions

Why is Surpim IM/IV prescribed?

It should not be used as a preventive painkiller before surgery. It belongs to the non-steroidal anti-inflammatory drug group, and it is given when pain is severe enough to need strong pain relief.

How should I take Surpim IM/IV?

Surpim IM/IV is given by a doctor or nurse as an injection, either into a vein or into a muscle. Do not inject it yourself unless a doctor has shown you how.

Can Surpim IM/IV cause side effects?

Surpim IM/IV can cause side effects. Patients should tell the doctor or nurse promptly if they notice any unusual symptom after receiving the injection.

Who should be careful with Surpim IM/IV?

Extra caution is needed in older patients. Surpim IM/IV 30 mg/ml injection must not be used by anyone allergic to it or to other NSAIDs, in children, or as a preventive painkiller before surgery.

Indications

Ketorolac Tromethamine is indicated for the short-term management of moderate to severe acute post-operative pain.

Pharmacology

Ketorolac Tromethamine is a potent analgesic of the non-steroidal anti-inflammatory drugs (NSAIDs). It acts by inhibiting the cyclooxygenase enzyme system and hence inhibits the prostaglandin synthesis. It demonstrates a minimal anti-inflammatory effect at its analgesic dose.

Dosage & Administration

Tablet-

Recommended dose is 10 mg every 4-6 hours. It should be used short-term only (up to 7 days) and are not recommended for chronic use. Doses exceeding 40 mg/day is not recommended.

Injection-

Ketorolac injection may be used as a single or multiple doses, on a regular or when necessary schedule for the management of moderately severe, acute pain that requires analgesia at the opioid level, usually in a postoperative setting. When administering Ketorolac injection, the IV bolus must be given over no less than 15 seconds. The IM administration should be given slowly and deeply into the muscle. The analgesic effect begins within 30 minutes with maximum effect in 1 to 2 hours after dosing IV or IM. Duration of analgesic effect is usually 4 to 6 hours.

Single-Dose Treatment-
IM Dosing (Adult):
  • Patients <65 years of age: One dose of 60 mg.
  • Patients >65 years of age, renally impaired and/or less than 50 kg of body weight: One dose of 30 mg.
IV Dosing (Adult):
  • Patients <65 years of age: One dose of 30 mg.
  • Patients >65 years of age, renally impaired and/or less than 50 kg of body weight: One dose of 15 mg.
IV or IM Dosing (2 to 16 years of age):
  • IM Dosing: One dose of 1 mg/kg up to a maximum of 30 mg.
  • IV Dosing: One dose of 0.5 mg/kg up to a maximum of 15 mg.
Multiple-Dose Treatment (IV or IM)-
  • Patients <65 years of age: The recommended dose is 30 mg Ketorolac injection every 6 hours. The maximum daily dose should not exceed 120 mg. Patients >65 years of age, renally impaired patients and patients less than 50 kg: The recommended dose is 15 mg Ketorolac injection every 6 hours. The maximum daily dose for these populations should not exceed 60 mg. For breakthrough pain, do not increase the dose or the frequency of Ketorolac Tromethamine.
  • Conversion from Parenteral to Oral Therapy: Ketorolac tablets may be used either as monotherapy or as follow-on therapy to parenteral Ketorolac. When Ketorolac tablets are used as a follow-on therapy to parenteral Ketorolac, the total combined daily dose of ketorolac (oral + parenteral) should not exceed 120 mg in younger adult patients or 60 mg in elderly patients on the day the change of formulation is made. On subsequent days, oral dosing should not exceed the recommended daily maximum of 40 mg. Ketorolac IM should be replaced by Ketorolac tablet as soon as feasible. The total duration of combined parenteral and oral treatment should not exceed 5 days.

Interaction

Other NSAIDs or aspirin: Increase the side effects of ketorolac Tromethamine.
Anti-coagulants: Enhance anti-coagulant effect.
Beta Blocker: Reduce the anti-hypertensive effect .
ACE Inhibitors: Increase the risk of renal impairment.
Methotrexate: Enhance the toxicity of methotrexate.

Contraindications

Ketorolac is contraindicated in patients having hypersensitivity to this drug or other NSAIDs. It should not be used in children under 16 years of age. lt is also contraindicated as prophylactic analgesic before surgery.

Side Effects

Commonly occurring side effects are nausea, vomiting, gastro-intestinal bleeding, melana, peptic ulcer, pancreatitis, anxiety, drowsiness, headache, excessive thirst, fatigue, bradycardia, hypertension, palpitation, chest pain, infertility in female and pulmonary edema.

Pregnancy & Lactation

US FDA Pregnancy category of Ketorolac Tromethamine is C. So, Ketorolac Tromethamine should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.

Precautions & Warnings

Caution should be exercised in patients over the age of 65 years. Caution should also be taken in patients with active or suspected peptic ulcer or gastrointestinal bleeding or asthma and liver dysfunction.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Ketorolac Tromethamine

Other brands with the same generic name, cheapest first.

See all 106 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.